FATE logo

Fate Therapeutics (FATE) Accounts Payable

Annual Accounts Payable

$4.72 M
-$3.55 M-42.90%

December 31, 2023


Summary


Performance

FATE Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Quarterly Accounts Payable

$6.35 M
+$854.00 K+15.54%

September 30, 2024


Summary


Performance

FATE Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFATEbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

FATE Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-42.9%+11.3%
3 y3 years-24.9%-35.6%
5 y5 years+12.2%+22.7%

FATE Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.2%at low-44.5%+34.5%
5 y5-year-45.2%at low-53.2%+70.8%
alltimeall time-45.2%+631.6%-53.2%+884.3%

Fate Therapeutics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$6.35 M(+15.5%)
Jun 2024
-
$5.50 M(-18.8%)
Mar 2024
-
$6.76 M(+43.4%)
Dec 2023
$4.72 M(-42.9%)
$4.72 M(-17.3%)
Sep 2023
-
$5.71 M(-24.0%)
Jun 2023
-
$7.51 M(-23.8%)
Mar 2023
-
$9.86 M(+19.2%)
Dec 2022
$8.27 M(-4.0%)
$8.27 M(-13.8%)
Sep 2022
-
$9.59 M(+13.9%)
Jun 2022
-
$8.42 M(-26.4%)
Mar 2022
-
$11.44 M(+32.9%)
Dec 2021
$8.61 M(+37.1%)
$8.61 M(+33.7%)
Sep 2021
-
$6.44 M(+11.6%)
Jun 2021
-
$5.77 M(-35.9%)
Mar 2021
-
$9.00 M(+43.2%)
Dec 2020
$6.28 M(+7.9%)
$6.28 M(+69.0%)
Sep 2020
-
$3.72 M(-72.6%)
Jun 2020
-
$13.56 M(+162.2%)
Mar 2020
-
$5.17 M(-11.1%)
Dec 2019
$5.82 M
$5.82 M(+1.9%)
Sep 2019
-
$5.71 M(+5.6%)
Jun 2019
-
$5.41 M(+0.8%)
DateAnnualQuarterly
Mar 2019
-
$5.37 M(+27.6%)
Dec 2018
$4.21 M(+150.6%)
$4.21 M(-19.7%)
Sep 2018
-
$5.24 M(+49.2%)
Jun 2018
-
$3.51 M(+62.5%)
Mar 2018
-
$2.16 M(+28.7%)
Dec 2017
$1.68 M(+79.7%)
$1.68 M(-23.7%)
Sep 2017
-
$2.20 M(+86.7%)
Jun 2017
-
$1.18 M(-52.3%)
Mar 2017
-
$2.47 M(+164.5%)
Dec 2016
$934.00 K(-6.2%)
$934.00 K(-22.2%)
Sep 2016
-
$1.20 M(-39.9%)
Jun 2016
-
$2.00 M(+1.2%)
Mar 2016
-
$1.98 M(+98.3%)
Dec 2015
$996.00 K(+54.4%)
$996.00 K(-22.2%)
Sep 2015
-
$1.28 M(-15.1%)
Jun 2015
-
$1.51 M(+18.6%)
Mar 2015
-
$1.27 M(+97.1%)
Dec 2014
$645.00 K(-5.4%)
$645.00 K(-44.3%)
Sep 2014
-
$1.16 M(+18.1%)
Jun 2014
-
$980.00 K(-26.3%)
Mar 2014
-
$1.33 M(+95.0%)
Dec 2013
$682.00 K(-44.5%)
$682.00 K(-44.5%)
Dec 2012
$1.23 M
$1.23 M

FAQ

  • What is Fate Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Fate Therapeutics?
  • What is Fate Therapeutics annual accounts payable year-on-year change?
  • What is Fate Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Fate Therapeutics?
  • What is Fate Therapeutics quarterly accounts payable year-on-year change?

What is Fate Therapeutics annual accounts payable?

The current annual accounts payable of FATE is $4.72 M

What is the all time high annual accounts payable for Fate Therapeutics?

Fate Therapeutics all-time high annual accounts payable is $8.61 M

What is Fate Therapeutics annual accounts payable year-on-year change?

Over the past year, FATE annual accounts payable has changed by -$3.55 M (-42.90%)

What is Fate Therapeutics quarterly accounts payable?

The current quarterly accounts payable of FATE is $6.35 M

What is the all time high quarterly accounts payable for Fate Therapeutics?

Fate Therapeutics all-time high quarterly accounts payable is $13.56 M

What is Fate Therapeutics quarterly accounts payable year-on-year change?

Over the past year, FATE quarterly accounts payable has changed by +$643.00 K (+11.27%)